Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.082 | 0.07 |
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.07 |
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |